{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T18:32:09Z","timestamp":1786991529744,"version":"build-2736575974"},"reference-count":54,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,25]],"date-time":"2026-02-25T00:00:00Z","timestamp":1771977600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100010018","name":"Liaoning Province Doctoral Start-up Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010018","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jbc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Biological Chemistry"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.jbc.2026.111330","type":"journal-article","created":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T17:05:06Z","timestamp":1772125506000},"page":"111330","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Mitotic spindle\u2013organizing protein 2A (MZT2A) promotes cisplatin resistance through NEMO ubiquitination and NF-\u03baB activation in lung adenocarcinoma"],"prefix":"10.1016","volume":"302","author":[{"given":"Huanxi","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhe","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yizhuo","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiping","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingqian","family":"Guan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zongang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7403-480X","authenticated-orcid":false,"given":"Xianghong","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jbc.2026.111330_bib1","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1097\/CM9.0000000000002108","article-title":"Cancer statistics in China and United States, 2022: profiles, trends, and determinants","volume":"135","author":"Xia","year":"2022","journal-title":"Chin. Med. J. (Engl)"},{"key":"10.1016\/j.jbc.2026.111330_bib2","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1097\/CM9.0000000000001474","article-title":"Changing profiles of cancer burden worldwide and in China: a secondary analysis of the global cancer statistics 2020","volume":"134","author":"Cao","year":"2021","journal-title":"Chin. Med. J. (Engl)"},{"key":"10.1016\/j.jbc.2026.111330_bib3","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1038\/s41571-023-00798-3","article-title":"The global burden of lung cancer: current status and future trends","volume":"20","author":"Leiter","year":"2023","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.jbc.2026.111330_bib4","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-020-67378-8","article-title":"Peritumoral and intratumoral radiomic features predict survival outcomes among patients diagnosed in lung cancer screening","volume":"10","author":"P\u00e9rez-Morales","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jbc.2026.111330_bib5","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000032899","article-title":"Non-small cell lung cancer (NSCLC): a review of risk factors, diagnosis, and treatment","volume":"102","author":"Alduais","year":"2023","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.jbc.2026.111330_bib6","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/j.jtho.2021.11.003","article-title":"The 2021 WHO classification of Lung Tumors: impact of Advances since 2015","volume":"17","author":"Nicholson","year":"2022","journal-title":"J. Thorac. Oncol."},{"key":"10.1016\/j.jbc.2026.111330_bib7","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1016\/j.jtho.2022.03.005","article-title":"The International Association for the Study of lung cancer thymic epithelial tumor staging Project: unresolved issues to be addressed for the next ninth edition of the TNM classification of malignant tumors","volume":"17","author":"Ruffini","year":"2022","journal-title":"J. Thorac. Oncol."},{"key":"10.1016\/j.jbc.2026.111330_bib8","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/s12943-023-01740-y","article-title":"Lung cancer immunotherapy: progress, pitfalls, and promises","volume":"22","author":"Lahiri","year":"2023","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.jbc.2026.111330_bib9","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1200\/JCO.22.00051","article-title":"Adjuvant systemic therapy and adjuvant radiation therapy for stage I-IIIA completely resected Non-Small-Cell Lung Cancer: ASCO Guideline rapid recommendation update","volume":"40","author":"Pisters","year":"2022","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.jbc.2026.111330_bib10","doi-asserted-by":"crossref","first-page":"384","DOI":"10.3390\/cancers13030384","article-title":"Immune resistance in lung adenocarcinoma","volume":"13","author":"Spella","year":"2021","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.jbc.2026.111330_bib11","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1200\/JCO.21.01845","article-title":"Managing resistance to immune checkpoint inhibitors in lung cancer: treatment and novel strategies","volume":"40","author":"Passaro","year":"2022","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.jbc.2026.111330_bib12","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1038\/s41571-022-00639-9","article-title":"Third-generation EGFR and ALK inhibitors: mechanisms of resistance and management","volume":"19","author":"Cooper","year":"2022","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.jbc.2026.111330_bib13","doi-asserted-by":"crossref","DOI":"10.1016\/j.drup.2021.100787","article-title":"Hypoxia as a driver of resistance to immunotherapy","volume":"59","author":"Kopecka","year":"2021","journal-title":"Drug. Resist. Updat."},{"key":"10.1016\/j.jbc.2026.111330_bib14","doi-asserted-by":"crossref","DOI":"10.1016\/j.critrevonc.2021.103327","article-title":"Tumor hypoxia: the major culprit behind cisplatin resistance in cancer patients","volume":"162","author":"Devarajan","year":"2021","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"10.1016\/j.jbc.2026.111330_bib15","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.semcancer.2023.11.006","article-title":"Tumor hypoxia and radiotherapy: a major driver of resistance even for novel radiotherapy modalities","volume":"98","author":"Beckers","year":"2024","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.jbc.2026.111330_bib16","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1007\/s10863-007-9080-3","article-title":"Hypoxia, glucose metabolism and the Warburg's effect","volume":"39","author":"Bartrons","year":"2007","journal-title":"J. Bioenerg. Biomembr"},{"key":"10.1016\/j.jbc.2026.111330_bib17","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/1476-4598-2-23","article-title":"Molecular responses to hypoxia in tumor cells","volume":"2","author":"Kunz","year":"2003","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.jbc.2026.111330_bib18","doi-asserted-by":"crossref","first-page":"6054","DOI":"10.3390\/cancers14246054","article-title":"Hypoxia-Inducible Factor-1: a novel therapeutic target for the management of cancer, drug resistance, and cancer-related pain","volume":"14","author":"Bui","year":"2022","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.jbc.2026.111330_bib19","first-page":"56","article-title":"Down-regulation of survivin and hypoxia-inducible factor-1 \u03b1 by \u03b2-elemene enhances the radiosensitivity of lung adenocarcinoma xenograft","volume":"27","author":"Li","year":"2012","journal-title":"Cancer Biother. Radiopharm."},{"key":"10.1016\/j.jbc.2026.111330_bib20","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1081\/CNV-200055970","article-title":"Review: tubulin function, action of antitubulin drugs, and new drug development","volume":"23","author":"Pellegrini","year":"2005","journal-title":"Cancer Invest."},{"key":"10.1016\/j.jbc.2026.111330_bib21","doi-asserted-by":"crossref","first-page":"988","DOI":"10.3389\/fmicb.2018.00988","article-title":"Mitotic-Spindle organizing protein MztA mediates septation signaling by suppressing the regulatory subunit of protein phosphatase 2A-ParA in Aspergillus nidulans","volume":"9","author":"Jiang","year":"2018","journal-title":"Front Microbiol."},{"key":"10.1016\/j.jbc.2026.111330_bib22","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1126\/science.1181348","article-title":"Systematic analysis of human protein complexes identifies chromosome segregation proteins","volume":"328","author":"Hutchins","year":"2010","journal-title":"Science"},{"key":"10.1016\/j.jbc.2026.111330_bib23","doi-asserted-by":"crossref","first-page":"3963","DOI":"10.1091\/mbc.e10-05-0408","article-title":"The gammaTuRC revisited: a comparative analysis of interphase and mitotic human gammaTuRC redefines the set of core components and identifies the novel subunit GCP8","volume":"21","author":"Teixid\u00f3-Travesa","year":"2010","journal-title":"Mol. Biol. Cell"},{"key":"10.1016\/j.jbc.2026.111330_bib24","doi-asserted-by":"crossref","first-page":"2210","DOI":"10.1111\/cas.14900","article-title":"MZT2A promotes NSCLC viability and invasion by increasing Akt phosphorylation via the MOZART2 domain","volume":"112","author":"Wang","year":"2021","journal-title":"Cancer Sci."},{"key":"10.1016\/j.jbc.2026.111330_bib25","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1080\/14728222.2023.2225767","article-title":"Modulating multidrug resistance to drug-based antitumor therapies through NF-\u03baB signaling pathway: mechanisms and perspectives","volume":"27","author":"Wu","year":"2023","journal-title":"Expert Opin. Ther. Targets"},{"key":"10.1016\/j.jbc.2026.111330_bib26","doi-asserted-by":"crossref","first-page":"10","DOI":"10.3390\/cells5010010","article-title":"Hypoxia induced NF-\u03baB","volume":"5","author":"D'Ignazio","year":"2016","journal-title":"Cells"},{"key":"10.1016\/j.jbc.2026.111330_bib27","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1038\/nrm3644","article-title":"Molecular control of the NEMO family of ubiquitin-binding proteins","volume":"14","author":"Clark","year":"2013","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.jbc.2026.111330_bib28","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1016\/j.cell.2013.05.014","article-title":"OTULIN antagonizes LUBAC signaling by specifically hydrolyzing Met1-linked polyubiquitin","volume":"153","author":"Keusekotten","year":"2013","journal-title":"Cell"},{"key":"10.1016\/j.jbc.2026.111330_bib29","doi-asserted-by":"crossref","first-page":"4589","DOI":"10.1038\/s41467-018-07042-y","article-title":"Sex specific function of epithelial STAT3 signaling in pathogenesis of K-ras mutant lung cancer","volume":"9","author":"Caetano","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jbc.2026.111330_bib30","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2313137120","article-title":"SOS1 and KSR1 modulate MEK inhibitor responsiveness to target resistant cell populations based on PI3K and KRAS mutation status","volume":"120","author":"Daley","year":"2023","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jbc.2026.111330_bib31","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1039\/D1MO00245G","article-title":"The miR-4732-5p\/XPR1 axis suppresses the invasion, metastasis, and epithelial-mesenchymal transition of lung adenocarcinoma via the PI3K\/Akt\/GSK3\u03b2\/Snail pathway","volume":"18","author":"Hu","year":"2022","journal-title":"Mol. Omics"},{"key":"10.1016\/j.jbc.2026.111330_bib32","doi-asserted-by":"crossref","first-page":"2451","DOI":"10.2147\/OTT.S193736","article-title":"LKB1 suppresses glioma cell invasion via NF-\u03baB\/Snail signaling repression","volume":"12","author":"Yuan","year":"2019","journal-title":"Onco. Targets Ther."},{"key":"10.1016\/j.jbc.2026.111330_bib33","doi-asserted-by":"crossref","first-page":"5632","DOI":"10.1038\/s41467-022-33290-0","article-title":"RAS oncogenic activity predicts response to chemotherapy and outcome in lung adenocarcinoma","volume":"13","author":"East","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jbc.2026.111330_bib34","doi-asserted-by":"crossref","DOI":"10.1080\/07853890.2024.2313671","article-title":"MUC1-EGFR crosstalk with IL-6 by activating NF-\u03baB and MAPK pathways to regulate the stemness and paclitaxel-resistance of lung adenocarcinoma","volume":"56","author":"Xu","year":"2024","journal-title":"Ann. Med."},{"key":"10.1016\/j.jbc.2026.111330_bib35","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1038\/s41419-021-03439-8","article-title":"Akt kinase LANCL2 functions as a key driver in EGFR-mutant lung adenocarcinoma tumorigenesis","volume":"12","author":"Lou","year":"2021","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.jbc.2026.111330_bib36","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1038\/s41416-019-0573-8","article-title":"Resistance mechanisms to osimertinib in EGFR-mutated non-small cell lung cancer","volume":"121","author":"Leonetti","year":"2019","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.jbc.2026.111330_bib37","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1158\/2159-8290.CD-23-0289","article-title":"Alveolar differentiation drives resistance to KRAS inhibition in lung adenocarcinoma","volume":"14","author":"Li","year":"2024","journal-title":"Cancer Discov."},{"key":"10.1016\/j.jbc.2026.111330_bib38","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2022.891593","article-title":"Alleviation of cisplatin-induced neuropathic pain, neuronal apoptosis, and systemic inflammation in mice by rapamycin","volume":"14","author":"Alotaibi","year":"2022","journal-title":"Front Aging Neurosci."},{"key":"10.1016\/j.jbc.2026.111330_bib39","doi-asserted-by":"crossref","first-page":"134","DOI":"10.3390\/ph12030134","article-title":"Special issue \"Anticancer Drugs\"","volume":"12","author":"Meegan","year":"2019","journal-title":"Pharmaceuticals (Basel)"},{"key":"10.1016\/j.jbc.2026.111330_bib40","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/1476-4598-8-10","article-title":"The centrosome protein NEDD1 as a potential pharmacological target to induce cell cycle arrest","volume":"8","author":"Tillement","year":"2009","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.jbc.2026.111330_bib41","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1038\/nature05697","article-title":"Synthetic lethal screen identification of chemosensitizer loci in cancer cells","volume":"446","author":"Whitehurst","year":"2007","journal-title":"Nature"},{"key":"10.1016\/j.jbc.2026.111330_bib42","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0063908","article-title":"Virtual and biophysical screening targeting the \u03b3-tubulin complex--a new target for the inhibition of microtubule nucleation","volume":"8","author":"Cala","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.jbc.2026.111330_bib43","doi-asserted-by":"crossref","DOI":"10.1590\/1678-4685-gmb-2023-0231","article-title":"LTBP2 regulates cisplatin resistance in GC cells via activation of the NF-\u03baB2\/BCL3 pathway","volume":"47","author":"Wang","year":"2024","journal-title":"Genet. Mol. Biol."},{"key":"10.1016\/j.jbc.2026.111330_bib44","doi-asserted-by":"crossref","first-page":"13","DOI":"10.3389\/fphar.2013.00013","article-title":"Modulators of HIF1\u03b1 and NFkB in cancer treatment: is it a rational approach for controlling malignant progression?","volume":"4","author":"Tafani","year":"2013","journal-title":"Front Pharmacol."},{"key":"10.1016\/j.jbc.2026.111330_bib45","doi-asserted-by":"crossref","first-page":"3101","DOI":"10.1007\/s00018-010-0404-9","article-title":"\"Without Ub I am nothing\": NEMO as a multifunctional player in ubiquitin-mediated control of NF-kappaB activation","volume":"67","author":"Gautheron","year":"2010","journal-title":"Cell Mol Life Sci"},{"key":"10.1016\/j.jbc.2026.111330_bib46","doi-asserted-by":"crossref","first-page":"566","DOI":"10.2174\/1871520621666210218175439","article-title":"Computational analysis of drug resistance network in lung adenocarcinoma","volume":"22","author":"Kara","year":"2022","journal-title":"Anticancer Agents Med. Chem."},{"key":"10.1016\/j.jbc.2026.111330_bib47","doi-asserted-by":"crossref","first-page":"153","DOI":"10.3892\/mmr.2015.4493","article-title":"Triptolide reverses the Taxol resistance of lung adenocarcinoma by inhibiting the NF-\u03baB signaling pathway and the expression of NF-\u03baB-regulated drug-resistant genes","volume":"13","author":"Jiang","year":"2016","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.jbc.2026.111330_bib48","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1186\/s13045-022-01292-6","article-title":"Hypoxia-inducible factors: master regulators of hypoxic tumor immune escape","volume":"15","author":"Wu","year":"2022","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.jbc.2026.111330_bib49","doi-asserted-by":"crossref","first-page":"29","DOI":"10.3892\/or.2024.8862","article-title":"Hypoxia studies in non-small cell lung cancer: pathogenesis and clinical implications (Review)","volume":"53","author":"Zhou","year":"2025","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.jbc.2026.111330_bib50","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1093\/neuonc\/noad017","article-title":"Single-cell transcriptomic analyses provide insights into the cellular origins and drivers of brain metastasis from lung adenocarcinoma","volume":"25","author":"Wang","year":"2023","journal-title":"Neuro Oncol."},{"key":"10.1016\/j.jbc.2026.111330_bib51","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.jtho.2015.09.009","article-title":"The IASLC lung cancer staging Project: proposals for revision of the TNM stage groupings in the forthcoming (Eighth) edition of the TNM classification for lung cancer","volume":"11","author":"Goldstraw","year":"2016","journal-title":"J. Thorac. Oncol."},{"key":"10.1016\/j.jbc.2026.111330_bib52","first-page":"1002","article-title":"Expert consensus on the pathological evaluation of neoadjuvant therapy efficacy for non-small cell lung cancer","volume":"50","year":"2021","journal-title":"Chin J. Pathol."},{"key":"10.1016\/j.jbc.2026.111330_bib53","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1021\/cb500653y","article-title":"Gliotoxin suppresses NF-\u03baB activation by selectively inhibiting linear ubiquitin chain assembly complex (LUBAC)","volume":"10","author":"Sakamoto","year":"2015","journal-title":"ACS Chem. Biol."},{"key":"10.1016\/j.jbc.2026.111330_bib54","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1186\/s13046-018-0855-7","article-title":"MKRN2 inhibits migration and invasion of non-small-cell lung cancer by negatively regulating the PI3K\/Akt pathway","volume":"37","author":"Jiang","year":"2018","journal-title":"J. Exp. Clin. Cancer Res."}],"container-title":["Journal of Biological Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021925826002000?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021925826002000?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T11:48:02Z","timestamp":1777463282000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021925826002000"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":54,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,4]]}},"alternative-id":["S0021925826002000"],"URL":"https:\/\/doi.org\/10.1016\/j.jbc.2026.111330","relation":{},"ISSN":["0021-9258"],"issn-type":[{"value":"0021-9258","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Mitotic spindle\u2013organizing protein 2A (MZT2A) promotes cisplatin resistance through NEMO ubiquitination and NF-\u03baB activation in lung adenocarcinoma","name":"articletitle","label":"Article Title"},{"value":"Journal of Biological Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jbc.2026.111330","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc on behalf of American Society for Biochemistry and Molecular Biology.","name":"copyright","label":"Copyright"}],"article-number":"111330"}}